Construction of plant to produce Belarusian coronavirus vaccine starts in Vitebsk Region

8 февраля 2022

The construction of a plant for the production of the Belarusian coronavirus vaccine has started in the Vitebsk Region. The assembly line will be supplied by two pharmaceutical manufacturers: Belmedpreparaty will produce the active ingredient and the finished vaccine will be manufactured at BelVitunifarm production facilities. Belarus intends to receive and release its own drug against COVID-19 in 2023.